Special Report | Markets in Turmoil: Airlines & Future of Sports
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
5 Maj 202045min
Warren Buffett: “Nothing can stop America”
Berkshire Hathaway’s 2020 annual shareholder meeting, the “Woodstock for Capitalists” -- which allows the company’s 40,000+ investors to question the Oracle of Omaha directly -- was hosted virtually for the first time ever. The four-hour live-streamed presentation and Q&A gave insight into Warren Buffett’s investing mindset amid the coronavirus crisis. Becky Quick joins the podcast with exclusive insight and highlights from the meeting. Chief Economic Adviser of Allianz, Mohamed El-Erian, discusses Warren Buffett’s take on the markets and the impact of the Fed’s emergency response to the coronavirus crisis. Plus, words of hope from Apple CEO Tim Cook to the class of 2020. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
4 Maj 202036min
Special Report | Markets in Turmoil: Gilead & COVID-19 Testing
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
2 Maj 202045min
Gilead’s Remdesivir, the Drug that Could Treat Covid-19
Gilead CEO Daniel O’Day shares details of Remdesivir’s two positive trials against Covid-19. He explains collaboration among global drugmakers, the process of finding a treatment for coronavirus, and worldwide, equitable distribution of the drug once it’s developed. CNBC’s Senior Health Science Reporter Meg Tirrell traces the history of Remdesivir, as well as the world’s response to pandemics in the past. In a conversation exclusive to Squawk Pod, Tirrell tracks the drugmakers still in the race for a Covid vaccine and treatment, and she explains covering the pandemic accurately amid rapidly evolving headlines. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
1 Maj 202037min
Special Report | Markets in Turmoil: Healthcare & Reopening
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
1 Maj 202044min
Elon Musk off Script; Jobless Claims with U.S. Labor Secretary; Former White House Insider Steve Bannon
Tesla CEO Elon Musk’s expletive-laced rant and subsequent tweet about American shelter-in-place orders has Wall Street and Main Street abuzz. The rolling total of Americans who’ve filed for unemployment in the last six weeks has topped 30 million; U.S. Labor Secretary Eugene Scalia assures Americans that there’s reason to hold on to optimism. Plus, former White House insider Steve Bannon takes on China and warns that the Chinese Communist Party will have to answer to citizens around the world who wonder about its role in the pandemic’s spread. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
30 Apr 202028min
Special Report | Markets in Turmoil: Gilead Latest
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
30 Apr 202044min
Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation
A new study from the NIAID revealed that at least 50% of Covid-19 patients treated with a 5-day dosage of Gilead’s Remdesivir reported improved symptoms and were discharged from the hospital within two weeks. Former FDA Commissioner Dr. Scott Gottlieb describes the treatment as “part of a better toolbox” for fighting the coronavirus, but “not a home run.” Plus, Mindy Grossman, CEO of WW International, (formerly known as Weight Watchers) discusses keeping her business and our bodies well during quarantine. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
29 Apr 202026min
